Lv12
40 积分 2024-11-16 加入
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
4小时前
已完结
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials
4小时前
已完结
ENHANCED LUNG FUNCTION IN A PATIENT WITH CYSTIC FIBROSIS AND ABPA TREATED WITH TEZEPELUMAB
1天前
已关闭
Allergic bronchopulmonary aspergillosis successfully treated with tezepelumab
1天前
已完结
皖公网安备34019202002308
